Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience

Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience

Background. Treatment results in patients with relapsed and refractory acute myeloid leukemia (AML) remain unsatis‑factory. Treatment options for these patients are limited.Aim. To retrospectively analyze the efficacy and safety of combined therapy with hypomethylating agents and venetoclax (VenHMA)...

Full description

Bibliographic Details
Main Authors: M. A. Granatkin, E. A. Nikitin, M. I. Kislova, E. S. Mikhailov, V. A. Doronin, S. V. Minenko, M. M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. E. Pochtar, S. A. Lugovskaya, Yu. N. Kobzev, V. V. Ptushkin, E. V. Rimashevskaya
Format: Article
Language:Russian
Published: ABV-press 2023-03-01
Series:Онкогематология
Subjects:
acute myeloid leukemia
refractory
relapse
venetoclax
hypomethylating agents
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/793

Internet

https://oncohematology.abvpress.ru/ongm/article/view/793

Similar Items